Stock data

基米-創 (4195)

基米-創 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$98.06M, up 69.1% from a year earlier. EPS over the last four quarters totals -NT$0.35.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 基米-創 in Insightr